The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

The FDA granted RMAT designation to nogapendekin alfa and CAR-NK for reversing lymphopenia in patients with cancer, with ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...

Thanks to decades of sustained, predictable federal investments and increases in pancreatic cancer research, the research ...

Pancreatic cancer is the third leading cause of cancer-related deaths in the country. The Ramone Foundation is hosting a ...

All Babbo Italian Eatery profits on Feb. 26 benefit pancreatic cancer research. It's part of the annual Baseball for Babbo ...